NEGATIVE ENDOSCOPY, What is the Diagnosis and Treatment?

GERD: How to. Failures

GERD: How to Manage Treatment Failures John Fang MD University of Utah Introduction GERD: condition of reflux of stomach contents causes troublesome symptoms and/complications Refractory GERD: poor response

GERD DIAGNOSIS & TREATMENT DISCLOSURES 4/18/2018

GERD DIAGNOSIS & TREATMENT Subhash Chandra MBBS Assistant Professor CHI Health Clinic Gastroenterology Creighton University, School of Medicine April 28, 2018 DISCLOSURES None 1 OBJECTIVES Review update

Refractory GERD : case presentation and discussion

Refractory GERD : case presentation and discussion Ping-Huei Tseng National Taiwan University Hospital May 19, 2018 How effective is PPI based on EGD? With GERD symptom 75% erosive 25% NERD Endoscopy 81%

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults hur till återvinna från prostataoperation Is This Information Right for Me? Yes, if: A doctor said that you have gastroesophageal

Unmet Needs in the Management of Gastroesophageal Reflux Disease

Unmet Needs in the Management of Gastroesophageal Reflux Disease Ronnie Fass MD Professor of Medicine Case Western Reserve University Chairman, Division of Gastroenterology and Hepatology Director, Esophageal

Heartburn, also referred to acid reflux, happens when stomach acid flows back (refluxes) into your esophagus.

WHILE almost everyone experiences mild heartburn from time to time and many individuals have some antacids or another medication on hand for its relief, talk to your doctor, if you have heartburn more

GERD: 2014 Dilemmas and Solutions. Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University

GERD: 2014 Dilemmas and Solutions Ronnie Fass MD, FACP Professor of Medicine Case Western Reserve University How to Maximize Your PPI Treatment? Improve compliance and adherance Fass R. Am J Gastroenterol.

Refractory GERD. Kenneth R. DeVault, MD, FACG President American College of Gastroenterology Chair Department of Medicine Mayo Clinic Florida

Refractory GERD Kenneth R. DeVault, MD, FACG President American College of Gastroenterology Chair Department of Medicine Mayo Clinic Florida Objectives Define the terminology associated with refractory

Hold the Wrap! There is so much more to be done!

Hold the Wrap! There is so much more to be done! (Well, a few things that can be done.) (Well, not all that much, really ) (But Blair has never killed anyone with a PPI!) Nicholas Shaheen, MD, MPH Center

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) Acid Reflux Acid reflux occurs when acid from the stomach moves backwards into the esophagus. Heartburn Heartburn is a symptom of acid reflux and GERD. It may feel

What can you expect from the lab?

Role of the GI Motility Lab in the Diagnosis and Treatment of Esophageal Disorders Kenneth R. DeVault MD, FACG, FACP Professor and Chair Department of Medicine Mayo Clinic Florida What can you expect from

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group)

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf

Drug Class Monograph

Drug Class Monograph Class: Proton Pump Inhibitors Drugs: Aciphex Sprinkle (rabeprazole), Dexilant (dexlansoprazole), Lansoprazole, Nexium (esomeprazole capsule, esomeprazole granules), Omeprazole, Pantoprazole,

Proton Pump Inhibitors

Market DC Proton Pump Inhibitors Override(s) Prior Authorization Quantity Limit** Approval Duration Preferred PPI: No Prior Authorization required Preferred PPI quantity override: Lifetime Non-Preferred

See Important Reminder at the end of this policy for important regulatory and legal information.

Clinical Policy: Reference Number: CP.CPA.209 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important

Page 1 of 5 Official reprint from UpToDate www.uptodate.com 2017 UpToDate Patient education: Acid reflux (gastroesophageal reflux disease) in adults (The Basics) Written by the doctors and editors at UpToDate

Refractory GERD: What s a Gastroenterologist To Do?

Refractory GERD: What s a Gastroenterologist To Do? Philip O. Katz, MD, FACG Chairman, Division of Gastroenterology Einstein Medical Center Clinical Professor of Medicine Jefferson Medical College Philadelphia,

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014

Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.09.01 Subject: Proton Pump Inhibitors Page: 1 of 7 Last Review Date: June 12, 2014 Proton Pump Inhibitors

235 60th Street, West New York, NJ T: (201) F: (201) Main Street, Hackensack, NJ T: (201)

235 60th Street, West New York, NJ 07093 T: (201) 854-4646 F: (201) 854-4647 810 Main Street, Hackensack, NJ 07601 T: (201) 488-0095 Barrett's Esophagus WHAT IS BARRETTT'S ESOPHAGUS? Barrett's esophagus

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease

ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease Philip O. Katz MD 1, Lauren B. Gerson MD, MSc 2 and Marcelo F. Vela MD, MSCR 3 1 Division of Gastroenterology, Einstein

https://www.uptodate.com/contents/acid-reflux-gastroesophageal-reflux-disease-in-adults-...

Page 1 of 10 Official reprint from UpToDate www.uptodate.com 2017 UpToDate The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.

National Digestive Diseases Information Clearinghouse

Barrett s Esophagus National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is Barrett s esophagus? Barrett s esophagus is

How to Manage Refractory Heartburn

May 2018 How to Manage Refractory Heartburn C. Prakash Gyawali, M.D. Professor of Medicine Division of Gastroenterology Disclosures: Medtronic (research, speakers bureau); Allergan (speakers bureau); Ironwood

Relieving Frequent Heartburn Day Through Night

Page 1 Relieving Frequent Heartburn Day Through Night Relieving Frequent Heartburn Day Through Night David Metz, MD Professor of Medicine University of Pennsylvania School of Medicine Philadelphia, PA

In the Name of God. Refractory GERD

In the Name of God Refractory GERD S Nasseri-Moghaddam MD, MPH, AGAF Associate Professor of Medicine Digestive Disease Research Institute Shariati Hospital, TUMS sianasseri@yahoo.com IAGH meeting, Ordibehesht

July 19, Division of Dockets Management Food and Drug Administration 5630 Fishers Lane Room 1061, HFA-305 Rockville, Maryland 20852

July 19, 2017 Division of Dockets Management Food and Drug Administration 5630 Fishers Lane Room 1061, HFA-305 Rockville, Maryland 20852 Re: Comments on Citizen s Petition #FDA-2017-P-2733 Herein, the

Gastroesophageal Reflux (GER) and Gastroesophageal Reflux Disease (GERD) in Adults

Gastroesophageal Reflux (GER) and Gastroesophageal Reflux Disease (GERD) in Adults National Digestive Diseases Information Clearinghouse What is GER? Gastroesophageal reflux (GER) occurs when stomach contents

Epidemiology Classic Symptoms of GERD

Definitions LARYNGOPHARYNGEAL REFLUX AND ITS ROLE IN PEDIATRIC OTOLARYNGOLOGY Wendy Mackey, APRN, CORLN SOHN Congress Meeting Washington, DC September 2012 Laryngopharyngeal Reflux (LPR) Retrograde movement

Gastroesophageal Reflux Disease (GERD)

Quality Department Guidelines for Clinical Care Ambulatory GERD Guideline Team Team Leader Joel J Heidelbaugh, MD Family Medicine Team Members R Van Harrison, PhD Learning Health Sciences Mark A McQuillan,

Appropriate Use of Proton Pump Inhibitors (PPIs) Anderson Mabour, Pharm.D., BCPS Clinical Pharmacy Specialist

Appropriate Use of Proton Pump Inhibitors (PPIs) Anderson Mabour, Pharm.D., BCPS Clinical Pharmacy Specialist Disclosures I have no actual or potential conflicts of interest to report in relation to this

GERD: Pitfalls and Pearls

GERD: Pitfalls and Pearls Gary W. Falk, M.D., M.S. Professor of Medicine Division of Gastroenterology Perelman School of Medicine of the University of Pennsylvania Conflicts of Interest Nothing to disclose

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)

Outline Quick basics on Proton Pump Inhibitors (PPIs) PPIs: Good or Bad? What are potential risks of PPI therapy? How to approach your patients American Gastroenterology Association (AGA) recommendations

Proton Pump Inhibitors Drug Class Prior Authorization Protocol

Proton Pump Inhibitors Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: November 15, 2017 Effective Date: January 1, 2018 This policy has been developed through review

GASTROESOPHAGEAL REFLUX DISEASE. William M. Brady

Drugs of Today 1998, 34(1): 25-30 Copyright PROUS SCIENCE GASTROESOPHAGEAL REFLUX DISEASE William M. Brady Section of General Internal Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania,

Epidemiology of Peptic Ulcer Disease

Epidemiology of Peptic Ulcer Disease Introduction Peptic Ulcer Disease (PUD) is disruption of the mucosal integrity of the stomach and/or duodenum leading to a local defect or excavation due to active

Index. Note: Page numbers of article titles are in boldface type.

Note: Page numbers of article titles are in boldface type. A Achalasia, barium esophagography for, 57 58 Acid pocket, 18 19 Acid-sensing ion, 20 Acupuncture, 128 Adiponectin, in obesity, 166 ADX10059 metabotropic

Drug Class Literature Scan: Proton Pump Inhibitors and Histamine-2 Receptor Antagonists

Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

Burning Issues in Gastroesophageal Reflux Disease (GERD)

3:45 4:45pm Burning Issues in GERD SPEAKER Prateek Sharma, MD, FACG, FACP Presenter Disclosure Information The following relationships exist related to this presentation: Prateek Sharma, MD, FACG, FACP,

Functional Heartburn and Dyspepsia

Functional Heartburn and Dyspepsia Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina Objectives Understand the means of diagnosing functional heartburn

Reflux of gastric contents, particularly acid, into the esophagus

Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,

Manometry Conundrums

Manometry Conundrums Gastroenterology and Hepatology Symposium February 10, 2018 Reena V. Chokshi, MD Assistant Professor of Medicine Division of Gastroenterology, Hepatology, & Nutrition Department of

The STRETTA Procedure

THE HEARTBURN AND REFLUX STUDY CENTER The STRETTA Procedure Introduction The STRETTA procedure is an advanced state-of-the-art endoscopic technique for the correction of all forms of reflux disease including:

The New GERD Guidelines

Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/gi-insights/the-new-gerd-guidelines/3834/

Achalasia is a rare disease with an annual incidence estimated REVIEWS. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:1020 1024 REVIEWS Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia BOUDEWIJN F. KESSING, ALBERT J. BREDENOORD, and ANDRÉ J. P. M. SMOUT

Gastroesophageal reflux disease (GERD) is a common chronic

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:743 748 Efficacy of Esophageal Impedance/pH Monitoring in Patients With Refractory Gastroesophageal Reflux Disease, on and off Therapy JASON M. PRITCHETT,*

Gastroesophageal Reflux Disease in Infants and Children

Gastroesophageal Reflux Disease in Infants and Children 4 Marzo 2017 Drssa Chiara Leoni Drssa Valentina Giorgio pediatriagastro@gmail.com valentinagiorgio1@gmail.com Definitions: GER GER is the passage

KK College of Nursing Peptic Ulcer Badil D ass Dass, Lecturer 25th July, 2011

KK College of Nursing Peptic Ulcer Badil Dass, Lecturer 25 th July, 2011 Objectives: By the end of this lecture, the students t will be able to: Define peptic pp ulcer Describe the etiology and pathology

Copy right protected Page 1

DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.

National Digestive Diseases Information Clearinghouse

Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach

National Digestive Diseases Information Clearinghouse

Gastritis National Digestive Diseases Information Clearinghouse What is gastritis? Gastritis is a condition in which the stomach lining known as the mucosa is inflamed, or swollen. The stomach lining contains

Gastroesophageal Reflux Disease (GERD)

Quality Department Guidelines for Clinical Care Ambulatory GERD Guideline Team Team Leader Joel J Heidelbaugh, MD Family Medicine Team Members R Van Harrison, PhD Medical Education Mark A McQuillan, MD

Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next?

Aliment Pharmacol Ther 2005; 22: 79 94. doi: 10.1111/j.1365-2036.2005.02531.x Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease where next? R. FASS, M. SHAPIRO, R. DEKEL

Disclosures. Heartburn and Barrett s Esophagus. Heartburn and Barrett s Esophagus. GERD is common in the U.S. None

Heartburn and Barrett s Esophagus None Disclosures Christian Mathy, MD University of California, San Francisco 2015 Heartburn and Barrett s Esophagus Heartburn and GERD GERD therapy Extraesophageal GERD

GERD: A linical Clinical Clinical Update Objectives

GERD: A Clinical Update Jeff Gilbert, M.D. University i of Kentucky Gastroenterology 11/6/08 Objectives To review the basic pathophysiology underlying gastroesophageal reflux disease To highlight current

Caffeine, drug interaction profile, 152t Calcium absorption, PPIs and, 156 Calcium carbonate, 130 Campylobacter infection, 155

INDEX Note: Page numbers in italics indicate figures. Page numbers followed by a t indicate tables. Gastroesophageal reflux disease is abbreviated as GERD. Abdominal pain, as side effect of PPIs, 149,

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium

The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia. Disclosures

The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia Lana Bistritz MD FRCPC Royal Alexandra Hospital GI Update 2016 Disclosures I have no relevant financial disclosures I will be discussing off

Speaker disclosure. Objectives. GERD: Who and When to Treat 7/21/2015

GERD: Who and When to Treat Eugenio J Hernandez, MD Gastrohealth, PL Assistant Professor of Clinical Medicine, FIU Herbert Wertheim School of Medicine Speaker disclosure I do not have any relevant commercial

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology

Management Challenges of the Gastrointestinal Tract (GIT) in Systemic Sclerosis (SSc) Presented by: Tracy M. Frech, MD, MS April 2016

Management Challenges of the Gastrointestinal Tract (GIT) in Systemic Sclerosis (SSc) Presented by: Tracy M. Frech, MD, MS April 2016 DISCLOSURES AND COPYRIGHT No financial or ethical conflicts of interest.

Putting Chronic Heartburn On Ice

Putting Chronic Heartburn On Ice Over the years, gastroesophageal reflux disease has proven to be one of the most common complaints facing family physicians. With quicker diagnosis, this pesky ailment

Patients with refractory gastroesophageal reflux disease: diagnostic tools

INVITED REVIEW Annals of Gastroenterology (2012) 25, 1-6 Patients with refractory gastroesophageal reflux disease: diagnostic tools Georgios P. Karamanolis a, Daniel Sifrim b Aretaieion Hospital, Athens

Gastroesophageal Reflux Disease, Paraesophageal Hernias &

530.81 553.3 & 530.00 43289, 43659 1043432842, MD Assistant Clinical Professor of Surgery, UH JABSOM Associate General Surgery Program Director Director of Minimally Invasive & Bariatric Surgery Programs

11/19/2012. Comparison between PPIs G CELL. Risk ratio (95% CI) Patient subgroup. gastrin. S-form of omeprazole. Acid sensitive. coated.

REGULATION OF GASTRIC ACID SECRETION Comparison between PPIs Omeprazole Lansoprazole Rabeprazole Pantoprazole Esomeprazole gastrin G CELL + Acid sensitive Yes T1/2 30-60 minutes Main elimination Enteric

Proton Pump Inhibitors. Description

Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.01 Subject: Proton Pump Inhibitors Page: 1 of 6 Last Review Date: June 24, 2015 Proton Pump Inhibitors

Management of Functional Dyspepsia (FD)

Management of Functional Dyspepsia (FD) Amy S. Oxentenko, MD, FACG Program Director and Associate Chair, IM Associate Professor of Medicine Mayo Clinic, Rochester Outline Define functional dyspepsia (FD)

Optimal Management of GERD with Dexlansoprazole - Extended plasma concentration and dosing flexibility with a dual delayed release PPI

Optimal Management of GERD with Dexlansoprazole - Extended plasma concentration and dosing flexibility with a dual delayed release PPI Jun Heng Lee, M.D. Samsung Medical Center, Sungkyunkwan University

Rumination Definition

Ronnie Fass MD, FACG Professor of Medicine Case Western Reserve University Chairman, Division of Gastroenterology and Hepatology Director, Esophageal and Swallowing Center MetroHealth Medical Center Cleveland,

Do You Know Your SATs? (Sugar, Acid blockers, Thinners) Laura Habighorst RN CAPA CGRN Heartland SGNA Spring Conference 2014

Do You Know Your SATs? (Sugar, Acid blockers, Thinners) Laura Habighorst RN CAPA CGRN Heartland SGNA Spring Conference 2014 Objectives Describe the anesthesia contraindications for the administration of

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

PROTON PUMP INHIBITORS, NON-PREFERRED FORMS: ACIPHEX (rabeprazole sodium EC) oral tablet ACIPHEX SPRINKLE (rabeprazole sodium DR) oral capsule ESOMEPRAZOLE STRONTIUM (esomeprazole strontium DR) oral capsule

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) Information for patients UHN Read this handout to learn about: What gastroesohageal reflux (GERD) is Signs and symptoms How your doctor will know if you have it Tests

GERD. Gastroesophageal reflux disease, or GERD, occurs when acid from the. stomach backs up into the esophagus. Normally, food travels from the

GERD What is GERD? Gastroesophageal reflux disease, or GERD, occurs when acid from the stomach backs up into the esophagus. Normally, food travels from the mouth, down through the esophagus and into the

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers

Motility - Difficult Issues in Practice and How to Investigate

Motility - Difficult Issues in Practice and How to Investigate Geoff Hebbard The Issues (Upper GI) Difficult Dysphagia Non-Cardiac Chest pain Reflux Symptoms Regurgitation Belching 1 The Tools Oesophageal

Approach to Patients with Non-Cardiac Chest Pain

Approach to Patients with Non-Cardiac Chest Pain Ronnie Fass, MD Professor of Medicine Case Western Reserve University Definition Noncardiac chest pain is defined as recurrent chest pain that is indistinguishable

GERD, peptic ulcer disease, and celiac disease: updates from the upper GI tract

GERD, peptic ulcer disease, and celiac disease: updates from the upper GI tract Primary Care Internal Medicine, October 15, 2018 Kyle Staller, MD, MPH Director, Gastrointestinal Motility Laboratory Center

Functional Dyspepsia

Functional Dyspepsia American College of Gastroenterology Boston Massachusetts, June 2015 Brian E. Lacy, PhD, MD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology

Heartburn is a common symptom among adults in

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:553 563 Early Heartburn Relief With Proton Pump Inhibitors: A Systematic Review and Meta-analysis of Clinical Trials KENNETH R. MCQUAID*, and LOREN LAINE

Effective Health Care

Effective Health Care Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease Executive Summary Background Gastroesophageal reflux disease (GERD), defined as weekly heartburn

Committee Approval Date: October 14, 2014 Next Review Date: October 2015

Medication Policy Manual Topic: esomeprazole-containing medications: - Nexium - Vimovo - esomeprazole strontium Policy No: dru039 Date of Origin: May 2001 Committee Approval Date: October 14, 2014 Next

CYP2C19-Proton Pump Inhibitors

CYP2C19-Proton Pump Inhibitors Cameron Thomas, Pharm.D. PGY2 Clinical Pharmacogenetics Resident St. Jude Children s Research Hospital February 1, 2018 Objectives: CYP2C19-PPI Implementation Review the

There are many different symptoms of GER. Your child may only have a few of these symptoms. The most common symptoms include:

This document is a short Overview of Pediatric Acid Reflux and GERD from www.reflux.org web site. Dozens of other documents about Pediatric GERD can be found in the Reading Room section of this web site.

Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy

Diseases of the Esophagus (2014) (2016), 29, 27 33 DOI: 10.1111/dote.12293 Original article Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy R. Mandaliya, 1 A.

Texas Prior Authorization Program Clinical Criteria. This criteria was recommended for review by an MCO to ensure appropriate and safe utilization.

Texas Prior Authorization Program Clinical Criteria Drug/Drug Class This criteria was recommended for review by an MCO to ensure appropriate and safe utilization. Clinical Information Included in this

A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?

Alimentary Pharmacology and Therapeutics A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? P. O. Katz*, D. A. Johnson

The normal esophagus is lined with squamous epithelium.

.. ALAN J. CAMERON, M.D. In Barrett's esophagus, the squamous lining of the lower esophagus is replaced by columnar epithelium. Barrett's esophagus is associated with gastroesophageal reflux and an increased

Alginates Extended Abstract

Alginates Extended Abstract III) Clinical practice guidelines: DeVault KR, Castell DO; American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux

Proton Pump Inhibitors:

Proton Pump Inhibitors: How bad could they be? Andrea Flanagan, Pharm.D. Iowa City VA Medical Center PGY-1 Pharmacy Resident Objectives for Pharmacists At the end of this presentation PHARMACISTS should

Surgical Evaluation for Benign Esophageal Disease. Kimberly Howard, PA-C, MHS Duke University Medical Center April 7, 2018

Surgical Evaluation for Benign Esophageal Disease Kimberly Howard, PA-C, MHS Duke University Medical Center April 7, 2018 Disclosures No disclosures relevant to this presentation. Objectives (for CME purposes)

Oesophageal Manometry and 24 hour ph monitoring A guide to the test

n The Leeds Teaching Hospitals NHS Trust Oesophageal Manometry and 24 hour ph monitoring A guide to the test Information for patients This leaflet is intended to answer some of the questions you may have

CMEARTICLE. WHAT CAN I DO IN MY PRACTICE? History. Daphne Ang 1, MBBS, FRCP (Edin), Choon How How 2, MMed, FCFP, Tiing Leong Ang 1, MBBS, FRCP (Edin)

Singapore Med J 2016; 57(10): 546-551 10.11622/smedj.2016167 CMEARTICLE Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy Daphne Ang 1, MBBS, FRCP (Edin), Choon How How

QUICK QUERIES. Topical Questions, Sound Answers

QUICK QUERIES Topical Questions, Sound Answers Dyspepsia: An Evidence-Based Approach Alan B. R. Thomson, MD, PhD, FRCPC, FACP, FACG Presented at the University of Alberta s Medical Grand Rounds, University

Patient information. Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4

Patient information Laryngopharyngeal Reflux ( LPR) Ear Nose and Throat Directorate PIF 1423/V4 You have been diagnosed with laryngopharyngeal reflux (LPR), otherwise known as extra-oesophageal reflux

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) Routine endoscopic investigation of patients of any age, presenting with dyspepsia

ENDOLUMINAL THERAPIES FOR GERD. University of Colorado Department of Surgery Grand Rounds March 31st, 2008

ENDOLUMINAL THERAPIES FOR GERD University of Colorado Department of Surgery Grand Rounds March 31st, 2008 Overview GERD Healthcare significance Definitions Treatment objectives Endoscopic options Plication

ORIGINAL ARTICLES ALIMENTARY TRACT

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:379 384 ORIGINAL ARTICLES ALIMENTARY TRACT Baclofen Improves Symptoms and Reduces Postprandial Flow Events in Patients With Rumination and Supragastric

Complex EoE patients. EoE is complicated

Complex EoE patients ACG Annual Meeting 10/17/2016 Evan S. Dellon, MD, MPH Center for Esophageal Diseases And Swallowing EoE is complicated Page 1 of 21 Overview 4 complex cases EoE non-response a diagnostic

Oesophageal Disorders

Oesophageal Disorders Anatomy Upper sphincter Oesophageal body Diaphragm Lower sphincter Gastric Cardia Symptoms Of Oesophageal Disorders Dysphagia Odynophagia Heartburn Atypical Chest Pain Regurgitation

Outline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments

Chronic Dyspepsia Eamonn M M Quigley MD FRCP FACP MACG FRCPI Lynda K and David M Underwood Center for Digestive Disorders Houston Methodist Hospital Houston, Texas Outline Definition (s) Epidemiology Pathophysiology

Four-Day Bravo ph Capsule Monitoring With and Without Proton Pump Inhibitor Therapy

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1083 1088 Four-Day Bravo ph Capsule Monitoring With and Without Proton Pump Inhibitor Therapy IKUO HIRANO, QING ZHANG, JOHN E. PANDOLFINO, and PETER J. KAHRILAS